Advertisement
Journal Home
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

41 Periodical Search Results

You searched for "platelet derived growth factor" OR "platelet-derived growth factor" within Lung Cancer

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

  Viewing 1-20  of 41 results   Next 20>

Results Page:  [1]  2  3

display abstract citation download email a colleague
Display:

  1. Moving beyond chemotherapy: novel cytostatic agents for malignant mesothelioma
    Hedy L Kindler
    Lung Cancer
    August 2004 (Vol. 45Supplement, Pages S125-S127)
    Abstract | Full Text | Full-Text PDF (69 KB)

  1. Angiogenesis and non-small cell lung cancer
    G Cox, J.L Jones, R.A Walker, W.P Steward, K.J O’Byrne
    Lung Cancer
    1 February 2000 (Vol. 27, Issue 2, Pages 81-100)
    Abstract | Full Text | Full-Text PDF (175 KB)

  1. Angiogenesis in non-small cell lung cancer: The prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood
    Roy M. Bremnes, Carlos Camps, Rafael Sirera
    Lung Cancer
    February 2006 (Vol. 51, Issue 2, Pages 143-158)
    Abstract | Full Text | Full-Text PDF (251 KB)

  1. Thromboxane receptor α mediates tumor growth and angiogenesis via induction of vascular endothelial growth factor expression in human lung cancer cells Corrected Proof, 26 October 2009
    Jingyan Wei, Weili Yan, Xiuling Li, Yunfei Ding, Hsin-Hsiung Tai
    Lung Cancer
    DOI: 10.1016/j.lungcan.2009.09.009
    Abstract | Full Text | Full-Text PDF (657 KB)

  1. Imatinib inhibits in vitro proliferation of cells derived from a pleural solitary fibrous tumor expressing platelet-derived growth factor receptor-beta , 28 November 2008
    Marco Prunotto, Martino Bosco, Lorenzo Daniele, Luigia Macri’, Lisa Bonello, Laura Schirosi, Giulio Rossi, Pierluigi Filosso, Baudolino Mussa, Anna Sapino
    Lung Cancer
    May 2009 (Vol. 64, Issue 2, Pages 244-246)
    Abstract | Full Text | Full-Text PDF (663 KB)

  1. Phase II study of docetaxel plus enoxaparin in chemotherapy-naive patients with metastatic non-small cell lung cancer: preliminary results
    Francisco Robert, Elizabeth Busby, Marisa B Marques, Robert E Reynolds, Delicia E Carey
    Lung Cancer
    November 2003 (Vol. 42, Issue 2, Pages 237-245)
    Abstract | Full Text | Full-Text PDF (209 KB)

  1. O-195 Activating mutations (muts) in the tyrosine kinase (TK)domain of the epidermal growth factor receptor (EGFR) and of the platelet-derived growth factor receptor α (PDGFRA) in gefitinib-treated non-small-cell lung cancer (NSCLC) patients
    M. Taron, C. Santarpia, Y. Ichinose, T. Mok, B. Massuti, C. Queralt, J. Sanchez, T. Jahan, D. Jablons, R. Rosell
    Lung Cancer
    July 2005 (Vol. 49Supplement 2, Page S65)
    Full-Text PDF (156 KB)

  1. Evidence that thrombin present in lungs of patients with pulmonary metastasis may contribute to the development of the disease
    N.A Hernández-Rodrı́guez, E Correa, A Contreras-Paredes, L Green
    Lung Cancer
    December 1999 (Vol. 26, Issue 3, Pages 157-167)
    Abstract | Full Text | Full-Text PDF (170 KB)

  1. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation
    F. Luppi, A.M. Longo, W.I. de Boer, K.F. Rabe, P.S. Hiemstra
    Lung Cancer
    April 2007 (Vol. 56, Issue 1, Pages 25-33)
    Abstract | Full Text | Full-Text PDF (497 KB)

  1. Targeting angiogenesis: a review of angiogenesis inhibitors in the treatment of lung cancer
    Srikala S. Sridhar, Frances A. Shepherd
    Lung Cancer
    December 2003 (Vol. 42, Issue 2, Supplement, Pages 81-91)
    Abstract | Full Text | Full-Text PDF (227 KB)

  1. Angiogenesis inhibitors under study for the treatment of lung cancer
    Frances A Shepherd, Srikala S Sridhar
    Lung Cancer
    August 2003 (Vol. 41Supplement 1, Pages 63-72)
    Abstract | Full Text | Full-Text PDF (221 KB)

  1. Diagnostic relevance of overexpressed mRNA of novel oncogene with kinase-domain (NOK) in lung cancers
    Tomoko Amachika, Daisuke Kobayashi, Ryosuke Moriai, Naoki Tsuji, Naoki Watanabe
    Lung Cancer
    June 2007 (Vol. 56, Issue 3, Pages 337-340)
    Abstract | Full Text | Full-Text PDF (264 KB)

  1. Targeted therapies for non-small cell lung cancer Corrected Proof, 16 November 2009
    Wolfram C.M. Dempke, Tamas Suto, Martin Reck
    Lung Cancer
    DOI: 10.1016/j.lungcan.2009.10.012
    Abstract | Full Text | Full-Text PDF (1052 KB)

  1. Imatinib in small cell lung cancer
    Jean-Charles Soria, Bruce E. Johnson, Thierry Le Chevalier
    Lung Cancer
    August 2003 (Vol. 41Supplement 1, Pages 49-53)
    Abstract | Full Text | Full-Text PDF (301 KB)

  1. Lung toxicity following chest irradiation in patients with lung cancer
    Raymond P Abratt, Graeme W Morgan
    Lung Cancer
    February 2002 (Vol. 35, Issue 2, Pages 103-109)
    Abstract | Full Text | Full-Text PDF (93 KB)

  1. The multi-targeted kinase inhibitor SU5416 inhibits small cell lung cancer growth and angiogenesis, in part by blocking Kit-mediated VEGF expression
    Julie Litz, G. Sakuntala Warshamana-Greene, Geoffrey Sulanke, Kenneth E. Lipson, Geoffrey W. Krystal
    Lung Cancer
    December 2004 (Vol. 46, Issue 3, Pages 283-291)
    Abstract | Full Text | Full-Text PDF (328 KB)

  1. Prognostic value of KIT expression in small cell lung cancer
    Ana López-Martin, Claudio Ballestín, Rocío Garcia-Carbonero, Angel Castaño, Fernando Lopez-Ríos, Angel López-Encuentra, Montserrat Sánchez-Cespedes, Daniel Castellano, Adela Bartolomé, Hernan Cortés-Funes, Luis Paz-Ares
    Lung Cancer
    June 2007 (Vol. 56, Issue 3, Pages 405-413)
    Abstract | Full Text | Full-Text PDF (256 KB)

  1. Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small-cell lung cancer (NSCLC)
    Toru Mukohara, Shinzoh Kudoh, Setsuko Yamauchi, Tatsuo Kimura, Naruo Yoshimura, Hiroshi Kanazawa, Kazuto Hirata, Hideki Wanibuchi, Shoji Fukushima, Kiyotoshi Inoue, Junichi Yoshikawa
    Lung Cancer
    August 2003 (Vol. 41, Issue 2, Pages 123-130)
    Abstract | Full Text | Full-Text PDF (562 KB)

  1. Platelet derived growth factor (PDGF) is a chemoattractant for human malignant mesothelioma cells
    J. Klominek, B. Baskin, D. Hauzenberger
    Lung Cancer
    September 1996 (Vol. 15, Issue 2, Pages 261-262)
    Full-Text PDF (284 KB)

  1. Regulation of differential expression of platelet-derived growth factor α- and β-receptor mRNA in normal and malignant human mesothelial cell lines
    C.A.J. van der Linden-van Beurden, A.W. Langerak, M.A. Versnel
    Lung Cancer
    September 1996 (Vol. 15, Issue 2, Page 263)
    Full-Text PDF (144 KB)
display abstract citation download email a colleague
Display:

  Viewing 1-20  of 41 results   Next 20>

Results Page:  [1]  2  3

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

Advertisement

Copyright © 2009 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.